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Abstract.  Certain properties of the highly specialized 
synaptic transmitter vesicles are shared by constitu- 
tively occurring vesicles. We and others have thus iden- 
tified a cDNA in various nonneuroendocrine cell types 
of rat and human that is related to synaptophysin, one 
of the major synaptic vesicle membrane proteins, which 
we termed pantophysin. Here we characterize the gene 
structure, mRNA and protein expression, and intracel- 
lular distribution of pantophysin. Its mRNA is detected 
in murine cell types of nonneuroendocrine as well as of 
neuroendocrine origin. The intron/exon structure of the 
murine pantophysin gene is identical to that of synapto- 
physin except for the last intron that is absent in panto- 
physin. The encoded polypeptide of calculated mol wt 
28,926 shares many sequence features with synapto- 
physin, most notably the four hydrophobic putative 
transmembrane domains, although the cytoplasmic end 
domains are completely different. Using antibodies 
against the unique carboxy terminus pantophysin can 
be detected by immunofluorescence microscopy in 
both exocrine and endocrine cells of human pancreas, 
and in cultured cells, colocalizing with constitutive 
secretory and endocytotic vesicle markers in non- 
neuroendocrine cells and with synaptophysin in cDNA- 
transfected epithelial cells. By immunoelectron micros- 
copy, the majority of pantophysin reactivity is detected 
at vesicles with a diameter of <100 nm that have a 
smooth surface and an electron-translucent interior. 
Using cell fractionation in combination with immu- 
noisolation, these vesicles are enriched in a light frac- 
tion and shown to contain the cellular vSNARE cellu- 
brevin and the ubiquitous SCAMPs in epithelial cells 
and synaptophysin in neuroendocrine or cDNA-trans- 
fected nonneuroendocrine cells and neuroendocrine 
tissues. Pantophysin is therefore a broadly distributed 
marker of small cytoplasmic transport vesicles indepen- 
dent of their content. 
T 
RANSPORT  between  discontinuous  cellular  mem- 
branes is dependent on the presence of small carrier 
vesicles.  Such  vesicles  have  been  identified  and 
characterized  in  various  pathways connecting,  e.g.,  ER 
and Golgi apparatus, cis- and trans-Golgi  cisternae,  Golgi 
apparatus and lysosomes, trans-Golgi network and plasma 
membrane, or plasma membrane and endosomes (for de- 
scription of such transport vesicles see references 4, 14, 28, 
48, 51-53; for review see references 19, 56, 57). While it 
has been shown in many instances  that the assembly of a 
defined "coat" is of importance for selective vesicle forma- 
tion from a donor membrane (for example see references 
2, 51, 55, 61, 65, 74), and that a multimolecular fusion com- 
plex is involved in vesicle fusion with a particular target 
membrane (for recent review see references 6, 20, 61, 66), 
very little is known about basic requirements for vesicle 
maintenance in the "free" cytoplasmic state. 
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A  suitable  model system to examine principles  deter- 
mining vesicle morphogenesis is the synaptic, transmitter- 
containing,  small  secretory vesicle in neurons. Its major 
components have been characterized,  and were shown to 
be, in large part, highly specific (6, 66). Interestingly, basic 
molecular principles  needed for structural and functional 
aspects  of synaptic  vesicle  recycling  are  also  shared by 
constitutive transport  vesicles,  and  are  conserved  from 
yeast to human (5, 20). 
Our interest has centered on synaptophysin (SPH)  1, one 
of the major integral membrane proteins of these trans- 
mitter-containing vesicles in neurons and of similar vesi- 
cles in cells of the dispersed neuroendocrine system (33, 42, 
50, 67, 75, 76). The observation that synaptophysin is able 
to induce the formation of voltage-sensitive channels upon 
reconstitution into planar lipid bilayers (68), that synapto- 
physin binds to the vesicular SNAP receptor (v SNARE) 
synaptobrevin, preferably synaptobrevin-2,  when it is not 
1. Abbreviations used in this paper. KLH, keyhole limpet hemocyanine; 
LAMP, lysosomal membrane protein; PPH, pantophysin; SCAMP, secre- 
tory carrier-associated membrane protein; v  SNARE, vesicular soluble 
N-ethylmaleimide sensitive factor attachment protein receptor, i.e., vesic- 
ular SNAP receptor; SPH, synaptophysin; TFR, transferrin receptor. 
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aptophysin  forms  a  freeze-thaw-sensitive  complex  to- 
gether with synaptobrevin and subunits of the vacuolar 
ATPase (25, 62) all suggested that it is important for syn- 
aptic vesicle to function. However, ablation of the synap- 
tophysin gene in mice did not affect growth, reproduction, 
or any other vital function under laboratory conditions, 
and functional synaptic vesicles were still present in these 
animals (17). It is therefore of interest to note that synap- 
tophysin is a member of a growing multigene family that 
includes synaptoporin/synaptophysin II (23, 37), which is 
also a neuron-specific synaptic vesicle protein, and panto- 
physin (PPH) whose mRNA was recently identified on the 
basis of its similarity to that of synaptophysin (40; see also 
reference 77). 
We now show that the pantophysin gene is closely re- 
lated to that of synaptophysin, but that mRNA and pro- 
rein  are  expressed  ubiquitously  in  tissues  and  cultured 
cells where the great majority of pantophysin is localized 
in  cytoplasmic microvesicles  of various  secretory, shut- 
tling, and endocytotic recycling pathways. Pantophysin, to- 
gether with other proteins with four membrane-spanning 
domains, may therefore fulfill basic housekeeping func- 
tions for all these small transport vesicles. 
Materials and Methods 
Reverse Transcription  and Polymerase Chain Reaction 
Reverse transcription of RNA with AMV reverse transcriptase and poly- 
merase chain reaction using amplimers SY-O-92502  and SY-O-9250f to 
amplify synaptophysin-related genes (see 40) or CB-O-931608 (5'-AAA 
GGA TCC GCC GAA ATG TCT ACA GGG GTG-3') and CB-O-931610 
(5'-AAA AAG CTF CAT CTT GCA GTT ~  CCA CCA-3') to amplify 
the cytoplasmic part of rat cellubrevin (47) were performed as described (40). 
A-Phage Isolation and Characterization 
A gene bank in h FIX II derived from genomic liver DNA of 129SVJ mice 
was purchased from Stratagene (La Jolla, CA). For isolation of panto- 
physin-encoding clones, a 536-bp BamHI-HindIII fragment was first am- 
plified from 3T3-Ll-derived cDNA with amplimers S¥-92502  and SY- 
92501 (cf. 40), and cloned into pBluescriptII KS (+) (Stratagene) resulting 
in plasmid bPM1. The random prime-labeled BamHI-HindIII insert of 
bPM1 was then used for gene bank screening (2.2 x  106 phages) to isolate 
phage hPM1 that was shown by nucleotide sequencing to contain the en- 
tire 3'-part of the gene. For completion of the 5'-end, a 648-bp AecI-PstI 
fragment was taken from a subclone of the insert of kPM1 and used as a 
random prime-labeled probe in another round of library screening. Re- 
striction maps were established for all isolated clones and overlapping 
fragments were subcloned into pBluescriptlI KS (+) and subjected to nu- 
cleotide sequencing of both strands. 
RNA Purification  and Northern Blot Hybridization 
RNA was purified from cultured cells following the procedure of Gough 
(27), and polyadenylated mRNA was further enriched by affinity chroma- 
tography using oligo(dT)-cellulose (Pharmacia, Uppsala, Sweden). Puri- 
fied RNA was electrophoretically separated through formaldehyde-con- 
taining agarose gels and transferred onto Biodyne B  nylon membranes 
(Pall, Portsmouth, UK) before hybridization with radioactively labeled ri- 
boprobes using standard procedures (cf. 40). For detection of murine pan- 
tophysin mRNA, plasmid cDNA clone bPM1 was linearized with HindIII, 
and labeled RNA was 15repared  with the help of T7-RNA-polymerase. 
After hybridization at 65°C under standard conditions (17),  filters were 
washed briefly at room temperature and twice for 20 min at 68°C in 0.1 x 
SSC/0.1% SDS, treated with 50 i~g/ml RNase A in 2 ×  SSC for 30 min at 
37°C, washed three times for 10 min at room temperature, and 30 rain at 
68°C in 0.1  x  SSC/0.1% SDS. 
Cell Culture and Transfection 
The following cell lines were used and propagated as described: Murine 
embryonic fibroblasts of line 3T3-L1  (ATCC CL 173),  murine pituitary 
tumor ceils of line AtT20 (ATCC CCL 89), murine pluripotent embryonic 
stem cells of line R1 (49), neuroendocrine rat adrenal pheochromocytoma 
cells of line PC12 (ATCC CRL 1721), epidermoid ceils of human vulvar 
carcinoma  line  A431  (ATCC  CRL  1555),  hepatocellular  carcinoma- 
derived PLC ceils (ATCC CRL 8024), and stably synaptophysin-express- 
ing sublines A431-5S4,  established from A431 cells, and PLC-6S4, derived 
from PLC cells (44). 
For transfection experiments several gene constructs were prepared. 
Oligonucleotides MY-O-941178 (5'-CGG AAC AAA AAC TGA TAT 
CCG AGG AAG ATC TGG-3') and MY-O-941179 (5'-CGC CAG ATC 
TI'C CTC GGA TAT CAG TI~ TTG TTC-3') coding for a defined myc 
epitope recognized by mAb MYC 1-9E10.2  (18)  were inserted into the 
NarI site of human pantophysin-encoding clone pPH2 (40)  to generate 
plasmid pMP1. For construction of pPM2, the myc epitope-coding se- 
quence was inserted into the first intravesicular loop by cloning oligonu- 
cleotides MY-O-941180  (5'-GAA CAA AAA CTG  ATA TCC  GAG 
GAA GAT CTC CCT GCA-3') and MY-O-941181  (5'-GGG AGA TCT 
TCC TCG GAT ATC AGT TTI" TGT TCT GCA-3') into the PstI site of 
pPH2. To add the cytoplasmic carboxy terminus of rat synaptophysin onto 
pantophysin, two fragments were amplified by PCR either from pPH2 
(amplimers PH-O-931968  [5'-AAA AAG C'IT ACG CAG TAT GGC 
GCC CAA CAT-3'] and PH-O-932292 [5'-AAA AGA TCT TAT TCC 
GGT AGG AGG TGG AAT-3']) or pSR  5 (amplimers SY-O-92553 [5'-AAA 
GAT CTG GCG CCC CGG AAA AGC AAC C-3'] and SY-O:603 [5'-GTG 
GAT CCC CCG GGC TGC AGG-3']), and combined after digestion with 
HindllI-BgllI  and  Bgllf-Pst[,  respectively, in  the  HindlIf-PstI-cleaved 
pBluescriptlI KS (+) vector resulting in plasmid pPS1. To add the myc 
epitope onto the carboxy terminus of human pantophysin, the BgllI-XbaI 
synaptophysin-containing fragment of pPS1 was substituted by oligonu- 
cleotides MY-O-94687 (5'-GAT CTG AAC AAA AAC TGA TAT CCG 
AGG AAG ATC T-3') and MY-O-94688 (5'-CTA GAG ATC TTC CTC 
GGA TAT CAG TIT TTG "I'TC A-3') to produce plasmid pPM1. The 
correct cloning was confirmed in each case by nucleic acid sequencing. In- 
serts were then further subcloned into the eukaryotic expression vectors 
pRC/CMV (Invitrogen, San Diego, CA) by integration of the appropriate 
fragments into HindlII-XbaI, or pBEHpacl8 (31) by insertion of the ap- 
propriate fragments into KpnI-Xbal. Synaptophysin gene construct pSR  1° 
has been described (44). 
Cells were transfected with purified DNA of appropriate gene con- 
structs using the calcium phosphate coprecipitation method and selected 
as previously described (44, 69). 
Expression of Recombinant Proteins in 
Escherichia  Coli 
The cytoplasmic end domains of human pantophysin were combined with 
vimentin to produce fusion proteins in E. coil The amino terminus of hu- 
man pantophysin was amplified with amplimers PH-O-95252  (5'-AAA 
CCA TGG CGC CCA ACA TCT ACT T-3') and PH-O-95253 (5'-AAA 
CCA TGG GCT CCT TGA GCG GGT TGA G-3') from plasmid pPH2 
(cf. 40). The resulting fragment was cut with NcoI and combined with the 
Ncol-HindlII  insert  of  the  human  vimentin-encoding plasmid  clone 
pDS5N/Hum-Vim-SD1 (30) in the E. coli expression vector pET-21d(+) 
(Novagen, Madison, WI) generating plasmid clone pETPV2. The carboxy 
terminus of human pantophysin was amplified from pPH2 with amplimers 
PH-O-95256  (5'-AAA TCT AGA TAC AAG GAG ACC AGC CTA 
CA-3')  and  PH-O-95257  (5'-AAA TCT  AGA  T/'A  TAT  TCC  GGT 
AGG AGG T-3'), and cloned after digestion with XbaI into the E. coli ex- 
pression-plasmid  pET3ad.vimentin.GFP  (kindly  provided  by  Dr.  M. 
Klymkowsky, University of Colorado at Boulder, Boulder, CO) that en- 
codes a chimera of Xenopus laevis vimentin-1 and green fluorescent pro- 
tein and was originally derived from pETadVimentin-l.stop (13). The new 
plasmid was termed pETVP1. 
Clone pAX-GalS1 coding for a fusion protein of [3-galactosidase  and 
the cytoplasmic carboxy terminus of rat synaptophysin in pAX5  ÷ (Medac, 
Hamburg, FRG) has been described recently (44). 
To produce the cytoplasmic carboxy terminus of murine synaptoporin, 
a 210-bp fragment was amplified from the recently isolated synaptoporin 
cDNA clone pPO2  (17)  with amplimers SO-O-951964  (5'-AAA GGA 
TCC TCA AGG AGA CTG GCT GGC AT-3') and SO-O-951965 (5'-AAA 
AAG CTI" TTA TAT CTG ATT GTT AAA GG-3'). The resulting frag- 
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HindIII sites of the prokaryotic expression vector pQE-42 (Qiagen, Chats- 
worth, CA) thereby creating construct DHFR-HisPo4 that encodes a fusion 
protein of dihydrofolate reductase with a poly-histidine tag and the car- 
boxy terminus of routine synaptoporin. 
The cytoplasmic amino terminus of rat cellubrevin was prepared from 
rat  liver cDNA  using amplimers CB-O-931608  and  CB-O-931610  (see 
above), and the BamHI-HindlII-cleaved products were cloned into the 
prokaryotic expression vector pQE-9 (Qiagen) resulting in clone HisRCB2. 
Recombinant proteins were expressed and purified from bacteria using 
protocols provided by Medac, Novagen, and Qiagen or those previously 
described (cf. 29, 41, 44). 
Production and Purification of  Antibodies 
The  following  antigens were  used for  immunizations of rabbit  and/or 
chicken:  (a)  synthetic  oligopeptides  P-PHC1  (KETSLHSPSNTSAPH- 
SQGGC), P-PHC2 (LHSPSNTSAPHSQGGC) and P-PHC3 (_CKETSLHS- 
PSNTSAPHSQGGIPPPTGI), all taken from the cytoplasmic carboxy ter- 
minus of human pantophysin (the underlined cysteines were added for 
coupling to keyhole limpet hemocyanine [KLH]); (b) synthetic oligopep- 
tide P-PHN1  (APNIYLVRQRISRLGQRMSGFQINLC)  corresponding 
to the cytoplasmic amino terminus of human pantophysin (the underlined 
cysteine was also included for coupling); and (c) the recombinant histi- 
dine-tagged amino terminus of rat cellubrevin enriched from bacteria that 
were transformed with plasmid HisRCB2 (see above). Purified fusion pro- 
teins, peptides, or peptides coupled to maleimide-activated KLH (Pierce, 
Rockford, IL) were injected repeatedly with or without adjuvans at 3-wk 
intervals. Chicken antibodies were enriched from eggs first by careful re- 
moval of egg white from egg yolk. After washing with water, the yolk 
membrane was punctured, and the effluent was homogenized in 20 ml 
TBS-buffer (10 mM Tris-HCl, pH 7.5, 140 mM NaCl) per egg yolk. After 
addition of 20 ml chloroform, mixing and incubation at 4°C for 24 h, the 
mixture was centrifuged (5,000 g, 15 min, 20°C). The upper phase was 
transferred to smaller centrifuge tubes that were stored for 10 min on ice 
and recentrifuged (27,500 g, 15 min, 4°C). Ammonium sulfate was slowly 
added to the supernatant (final concentration: 29.1 g/lO0 ml). After incu- 
bation at 4°C for 10 min, antibodies were concentrated by centrifugation 
(12,000 g, 10 min, 4°C), and the pelleted material was dissolved in PBS and 
dialyzed against PBS. 
Enriched chicken antibodies or sera produced in rabbits were further 
purified by affinity chromatography. To this end recombinant protein was 
coupled through a spacer to N-hydroxysuccinimide  esther-activated agarose 
beads (Affi-Gel 10 from BioRad, Hercules, CA). Binding was done in 0.1 
M MOPS, pH 7.5 for 4 h at 4°C. After several washes with 0.5 M sodium 
phosphate buffer (pH 7.5), the matrix was washed with 1 M NaC1/0.05  M 
sodium phosphate buffer (pH 7.5), and remaining binding sites were sub- 
sequently saturated by incubation in 100 mM ethanolamine (pH 7.5) over- 
night at 4°C. Serum diluted 1:10 in 10 mM Tris-HC1 (pH 7.5) was then 
loaded on the column preequilibrated in the same buffer followed by ex- 
tensive washing with 10 mM Tris-C1 (pH 7.5) and several washes with 0.5 
M  NaCl/10 mM Tris-HCl (pH 7.5).  Specifically bound antibodies were 
eluted either with 100 mM glycine (pH 2.5) and/or 100 mM triethylamine 
(pH 11.5), and directly diluted 1:2 in 1 M Tris-HC1 (pH 8.0). Affinity-puri- 
fied antibodies were used either directly after dialysis against PBS or after 
ammonium sulfate precipitation. 
Immunofluorescence and Immunoelectron Microscopy 
The following antibodies were used: murine mAbs against synaptophysin 
(SY38;  75), secretory carrier-associated membrane proteins (SCAMPs) 
(SG7C12; kindly provided by Dr. J.D. Castle; 7), human transferrin recep- 
tor (TFR) (B3/25; Boehringer, Mannheim, FRG; H68.4 kindly provided 
by  Dr.  I.S.  Trowbridge;  73),  a  defined  myc epitope  (MYC  1-9E10.2; 
ATCC CRL 1729;  18), and the lysosomal membrane proteins, LAMP-1 
(antibody H4A3) and LAMP-2 (antibody H4B4), from the Developmen- 
tal Studies Hybridoma Bank (Iowa City, IA), as well as affinity-purified 
antibodies from rabbit against [3-COP (kindly provided by Dr. T. Kreis; 
"anti-EAGE" in 15). 
For immunofluorescence microscopy, 5 Ixm cryosections were treated 
with acetone (-20°C, 10 min), and cultured cells were either fixed with 
methanol (-20°C, 5 min) and acetone (-20°C, 10 s), or after a brief treat- 
ment with saponin (0.1~).5% for 10-40 s) with 2% formaldehyde (room 
temperature, 30 min). Cells were further processed as described (44) for 
single and double immunofluorescence, and viewed with a conventional 
epifluorescence microscope (Axiophot, Carl Zeiss, Jena, FRG) or a con- 
focal laser scan microscope (LSM 410, Carl Zeiss). Laser scan images of dou- 
ble immunofluorescence labelings were obtained by simultaneous scan- 
ning of the sections in the same focal plane (thickness ~0.8 ~m) with a 
helium-neon laser at h  =  543 nm and an argon-ion laser at ~  =  488 nm 
measuring emission at h =  590-610 nm and at k = 510-525 nm. Secondary 
antibodies coupled to Texas red, the cyanine Cy2, or fluorescein-isothiocyanate 
were purchased from Dianova (Hamburg, FRG) or Biotrend (Kt~ln, FRG). 
For immunoelectron microscopy cells were grown to near confluency 
on glass coverslips. Cells were permeabilized by a gentle treatment with 
0.04% saponin in PBS/1 mM MgC12 for 30 s. Primary affinity-purified anti- 
bodies were diluted with PBS/1 mM MgCI2, and cells were incubated for 
20 min at room temperature. After several washings in PBS/1 mM MgC12, 
cells were fixed with freshly prepared 2% formaldehyde for 20 min. After 
quenching with 50 mM NI-I4C12 in PBS for 2  ×  5 min 6-nm-gold coupled 
secondary antibodies (Biotrend) were added at room temperature for up 
to 3 h. Several washings with PBS (2 ×  3 min) followed and cells were 
postfixed and further processed for electron microscopy as described (44). 
Cell Fractionation and Immunoblotting 
Cultured cells and frozen tissue samples that were cut into small pieces 
were routinely lysed by suspension in H buffer (10 mM triethylamine-ace- 
tic acid, pH 7.4, 1 mM EGTA, 1 mM EDTA, 2 mM DTT, 2 I~g/ml E-64, 40 
I~g/ml bestatin, 1 Ixg/ml pepstatin, and 20 I~M APMSF) and homogenized 
with 30 up and down strokes in a  tight-fitting Dounce homogenizer. In 
some experiments cell lysates were first centrifuged at 1,000 g for 10 min 
resulting in pellet P1 and supernatant $1 that was recentrifuged at 7,000 g 
for 10 min yielding pellet P2 and supernatant $2. Centrifugation of $2 at 
15,000 g for 10 min generated pellet P3 and supernatant $3, and further 
centrifugation of $3 at 100,000 g for 30 min resulted in pellet P4 and super- 
natant $4. Extraction of either pellet fraction with Triton X-100 (incuba- 
tion overnight in 1% Triton X-100 in H  buffer) and recentrifugation at 
100,000 g for 30 rain produced pellet fractions PI', P2', P3', and P4' and 
the corresponding superuatants $1', $2', $3', and $4'. 
For immunoisolation 15,000 g  supernatants were first prepared from 
homogenized cell or tissue lysates in H  buffer. Magnetic beads (rat anti- 
mouse IgGl-coated Dynabeads M-450 and sheep anti-rabbit IgG-coated 
Dynabeads M-280) were obtained from Dynal (Hamburg, FRG). In addi- 
tion, rabbit anti-chicken IgY antibodies (Sigma) were coupled to p-tolue- 
nesulfonylchloride-activated Dynabeads M-450 (Dynal) in the following 
way: 300 t~g secondary antibody (in 2-ml coupling buffer containing 50 mM 
borate, pH 9.5) was added to 8 ×  108 beads (~2 ml), and the mixture was 
incubated at room temperature for 24 h. After three washes for several 
hours with 10 ×  PBS/0.1% (wt/vol) BSA beads were resuspended in 10 × 
PBS/0.1%  (wt/vol) BSA and stored at 4°C. 6.7 ×  107 magnetic particles 
coated with appropriate  secondary antibodies were incubated with pri- 
mary antibodies for 2 h in 5 ml isolation buffer (10 mM EGTA, 250 mM 
sucrose, and 0.1% (wt/vol) BSA in PBS). Beads were washed three times 
for  10 min at room temperature  in 5  ml isolation buffer, treated  with 
blocking  solution  (10  mg/ml L-a-phosphatidylcholine (Sigma)  isolation 
buffer) for 1 h, and incubated for 1 h with up to 10 mg protein obtained 
from 15,000 g supernatants. Subsequently, beads were first washed 5 ×  10 
min in isolation buffer, and then briefly in high salt buffer (1 M KC1 in iso- 
lation buffer), and finally in isolation buffer (2 ×  5 min). The immunoiso- 
luted material was either directly analyzed by SDS-PAGE and immunoblot- 
ting, or was fixed and embedded for electron microsocopy as described (44). 
Linear sucrose gradients ranging from 15%  (wt/vol) to 60%  (wt/vol) 
sucrose for equilibrium gradient centrifugation or from 15%  (wt/vol) to 
45 % (wt/vol) sucrose for velocity gradient centrifugation (the sucrose was 
dissolved in 10 mM triethylamine-acetic acid, pH 7.4, 1 mM EGTA, 1 mM 
EDTA, 2 mM DT'I?, and 2 p.M APMSF) were layered on top of 70% (wt/ 
vol) sucrose pads. Approximately 500-1,000 I~g of protein contained in 
Sl-fractions (50-200 I-d) were loaded on top of each gradient, and centrif- 
ugation was performed in an SW40 Ti rotor (Beckman Instruments, Palo 
Alto, CA) at 8°C for either 17.5 h at 140,000 g (equilibrium gradients) or 
160 min at 270,000 g (velocity gradients). Fractions were collected from top 
to bottom and further analyzed by an ELISA as recently described (39, 44). 
Results 
Similarities in Amino Acid Sequence and Gene 
Structure of Pantophysin and Synaptophysin 
We  recently  identified,  in reverse  transcription-PCR  ex- 
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endocrine cells that encode a protein which is related to 
the neuroendocrine vesicle protein synaptophysin, which 
we termed pantophysin (40). We have now used the same 
experimental approach to isolate and clone a murine pan- 
tophysin eDNA fragment from 3T3-L1 flbroblasts. The am- 
plified cDNA in plasmid clone bPM1  showed significant 
homology  to  human  and  rat  pantophysin  (84.6%  and 
92.2%  nucleic  acid  identity,  respectively). To determine 
the gene structure of pantophysin, we used this cDNA to 
screen a murine h-phage library. From the 21 clones iso- 
lated, the two phages hPM1  and hPM2  with overlapping 
inserts  contained  the  entire  pantophysin  gene  together 
with some additional flanking regions. The complete nu- 
cleic acid  sequence  was determined  for the pantophysin 
gene of ~23 kb. Fig. 1 shows the entire derived amino acid 
sequence of the encoded polypeptide with a calculated tool 
wt of 28,926 including the start methionine. Murine panto- 
physin is 83 %  identical to the human orthologue (40) and 
shares a significant amino acid sequence identity with rat 
synaptophysin  (43%  identity;  42,  67).  Pantophysin  con- 
tains,  similar  to  synaptophysin,  four  23-29-amino  acid 
long  segments  of significant  hydrophobicity assumed  to 
form transmembrane domains (see Fig. 1), which, in con- 
trast to synaptophysin, are not predicted  to be a  helices 
(26).  Other  conserved  features  (Fig.  1)  are  a  potential 
N-glycosylation  site  (for  identification  in  rat  synapto- 
physin see 43) in the first intravesicular loop domain (N72), 
paired cysteine residues in both intravesicular loops (C64, 
C99 ,  C194,  C202) ,  and  charged  residues  within  transmem- 
brahe domains (K37, D154) including the lysine residue in 
transmembrane segment 1 that was previously shown to 
be important for the correct topogenesis of synaptophysin 
(41).  However, there are also properties that distinguish 
the pantophysins from the synaptophysins: they are highly 
basic (calculated isoelectric point 9.00 for murine panto- 
physin  vs 4.74  for rat  synaptophysin;  see  also  75),  they 
have an additional charged residue in transmembrane do- 
main 1 (E40), another cysteine in transmembrane domain 2 
(C130), and, most importantly, they are completely differ- 
ent in their cytoplasmic end domains. While the amino ter- 
mini do not share significant sequence homology, the char- 
acteristic cytoplasmic carboxy terminus of synaptophysin 
is absent in human and mouse pantophysin that have both 
only a short 26-amino acid end domain lacking the multi- 
ple tyrosine-containing motifs of synaptophysin and con- 
taining serines that are not embedded in typical phospho- 
rylation consensus sites. 
By  alignment  of  the  human,  rat,  and  murine  panto- 
physin  cDNAs  with  the  murine  pantophysin  gene  se- 
quence, the complete gene structure could be established 
identifying 6  exons  that  are interrupted  by 5  introns  of 
considerable size (Fig. 1). Remarkably, all 5 introns are lo- 
cated exactly at the corresponding positions in human and 
rat synaptophysin (Fig. 1; see also references 1, 54). On the 
other  hand,  pantophysin  does  not  have  a  sixth  intron 
which is present in the synaptophysin genes where it inter- 
rupts the 3'-noncoding region (Fig. 1). 
Expression of Pantophysin mRNA in Neuroendocrine 
and Nonneuroendocrine Cells 
Using  the  murine  pantophysin  cDNA  clone  bPM1  in 
Northern blot hybridization experiments, we analyzed the 
expression  of pantophysin  in  various  murine  cell  lines. 
Pantophysin mRNA could be identified under high stringency 
conditions in many different cell types including pluripotent 
embryonal stem cells, fibroblast-derived 3T3-L1 cells, and, 
most importantly, neuroendocrine pituitary tumor-derived 
AtT20 cells, although at a somewhat lower level (Fig. 2). 
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Figure  1.  Comparison  of  the  complete 
amino acid sequences of murine pantophysin 
(pph.mm),  human  pantophysin  (pph.hs), 
and  rat  synaptophysin  (sph.rn) as  deter- 
mined  from  the  encoding  genes  (1;  this 
study) or cDNA (40). Amino acids (one let- 
ter code; *, stop codons) conserved between 
either one or both of the pantophysins  and 
synaptophysin  are denoted by bold face let- 
ters and residue  numbers given on the left. 
Potential  transmembrane domains  of high 
hydrophobicity are labeled as ml, m2, m3, 
and m4. The conserved N-glycosylation site 
is marked by a star, conserved charged resi- 
dues in the transmembrane domains 1 and 3 
by  black  diamonds,  the  charged  residue 
present only in the transmembrane domain 
1 of the pantophysins by a white diamond, 
the conserved cysteine residues in the intra- 
vesicular loops by black circles, and the cys- 
teine residue present only in the transmem- 
brane domain 2 of the pantophysins by a 
white circle. Intron positions and neighbor- 
ing nucleotide  sequences (capital letters, ex- 
ons;  small letters, introns)  are  shown  to 
demonstrate the localization  of introns  1-5 
and of intron 6 that is only present in the 
3'-noncoding region of rat synaptophysin. 
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ized with a pantophysin-specific cRNA probe. Exposure was for 
1 h  at left, lanes 1-5; and overnight at right, lanes 1 '--5', RNAs 
were extracted from fibroblast-derived 3T3-L1  cells (20 Ixg total 
RNA, lanes I  and 1 '; 20 ~g poly(A)+-RNA, lanes 2 and 2 3, pitu- 
itary tumor-derived AtT20 cells (20 ~g total RNA, lanes 3 and 3 '; 
20 txg poly(A)+-RNA,  lanes 4 and 4'), and pluripotent embryonal 
stem cells of line R1  (20  Ixg poly(A)÷-RNA, lanes 5  amd 5'). 
Note  that  pantophysin mRNA  is not  only detectable in  non- 
neuroendocrine 3T3-L1 and R1 cells but also, after extended ex- 
posure, in neuroendocrine AtT20 cells (lanes 3' and 4'). The na- 
ture  of  the  weaker  reacting  upper  RNA  (*)  is  not  known. 
Positions of 28S and 18S RNAs are shown on the right margins 
(dots). 
Intracellular Localization of Epitope-tagged 
Pantophysin in Transfected Cells 
To  examine  the  intracellular localization of pantophysin, 
constructs were prepared in which DNA fragments coding 
for defined epitopes were inserted in different regions of 
the pantophysin cDNA. After transfection of appropriate 
gene  constructs  into  cultured  cells  transgene  products 
were detected by immunofluorescence microscopy (Fig. 3). 
Typically, pantophysin was seen in multiple dotlike struc- 
tures  that  were best resolved in the peripheral fiat cyto- 
plasm with increased staining near the plasma membrane 
of  neighboring  cells.  Immunofluorescence  was  variable 
around  the nucleus  for all transfectants  and ranged from 
partial caps, to circumferential crowns and dense regions 
covering the entire nucleus. The characteristic multipunc- 
tate localization, however, was the same for all constructs 
independent  of  the  type  of  epitope  tag  (compare  con- 
structs PM1 with PS1 in Fig. 3, c and e) and of the position 
of the  epitope tag (compare  constructs MP1  and PM1  in 
Fig. 3, b  and c). Even the addition of the long cytoplasmic 
carboxy-terminal extension  of synaptophysin  (cf.  Fig.  1) 
Figure 3.  Immunofluorescence microscopy of hepatocellular car- 
cinoma-derived PLC cells (methanol/acetone fixation) 3 d  after 
transfection with cDNA constructs encoding epitope-tagged hu- 
man pantophysin. The expressed polypeptides are drawn sche- 
matically in scale in a with the transmembrane domains in black, 
the myc epitope in gray, and the synaptophysin carboxy terminus 
in a diagonally striped pattern (protein denomination at left; wild- 
type pantophysin (PPtI) is shown for comparison). (b) Immuno- 
fluorescence micrograph and corresponding phase contrast (b') 
of  two  cells  expressing  MP1  after  reaction  with  mAb  MYC 
1-9E10.2 detecting the myc epitope at the amino terminus of pan- 
tophysin. (c)  Immunofluorescence microscopy and correspond- 
ing phase contrast (¢ ') of cells expressing PM1 that are stained by 
mAb MYC  1-9E10.2  detecting the myc epitope at the carboxy 
terminus of pantophysin. (d) Immunofluorescence of cells that 
were transfected with a construct coding for PM2 and were incu- 
bated with the myc antibody MYC 1-9E10.2  for 3 h before fixa- 
tion and incubation with secondary antibodies only. Only the single 
transfected cell shown  is strongly labeled. (e)  Immunofluores- 
cence microscopy of ceils expressing PS1 that is detected by mAb 
SY38 detecting pantophysin fused to the cytoplasmic  carboxy ter- 
minus  of synaptophysin. Note  that  all transfected cells show  a 
multipunctate cytoplasmic staining with variable labeling of the 
perinuclear region. Bars, 20 ~m. 
Haass et al. Pantophysin:  Gene, Expression  and Localization  735 Figure4. Immunoblot characterization of peptide antibodies against defined epitopes of pantophysin, synaptophysin, and synaptoporin. 
a shows Coomassie blue-stained polypeptides that were separated by 12%  SDS-PAGE. Enriched fusion proteins produced in E. coli 
were loaded. They were synthesized from plasmids pETVP1 (lane 1), coding for Xenopus laevis vimentin-1  with the cytoplasmic car- 
boxy terminus of human pantophysin; pETPV2 (lane 2), coding for the cytoplasmic amino terminus of human pantophysin fused to hu- 
man vimentin; pET3ad.vimentin.GFP (lane 3), coding for a chimera consisting  of Xenopus laevis vimentin-1  and green fluorescent pro- 
tein; pAX-GalS1 (lane 4), coding for 13-galactosidase with the cytoplasmic carboxy terminus of rat synaptophysin; and DHFR-HisPo4 
(lane 5), coding for dihydrofolate reductase with a poly-histidine tag and the cytoplasmic carboxy terminus of murine synaptoporin. The 
marker lanes contain the following polypeptides from top to bottom: at left BSA, M  r 66,000; ovalbumin, Mr 45,000; glyceraldehyde-3- 
phosphate dehydrogenase, Mr 36,000; carbonic anhydrase, Mr 29,000; trypsinogen, Mr 24,000; trypsin inhibitor, Mr 20,100; at right myo- 
sin heavy chain, Mr 205,000; 13-galactosidase, Mr 116,000; phosphorylase b, Mr 97,400; BSA, Mr 66,000; ovalbumin, Mr 45,000; carbonic 
anhydrase, Mr 29,000. (b-f) Similar gels to that shown in a (corresponding lanes are labeled and positions of molecular mass markers are 
indicated by dots) were prepared and polypeptides were transferred onto nitrocellulose filters that were incubated with different antibod- 
ies: (b) affinity-purified antibodies from rabbit against the carboxy terminus of human pantophysin (peptide P-PHC2); (c) affinity-purified 
antibodies from chicken against the carboxy terminus of human pantophysin (peptide P-PHC3); (d) affinity-purified antibodies from 
rabbit against the amino terminus of human pantophysin (peptide P-PHN1); (e) mAb SY38 against the carboxy terminus of synapto- 
physin (for epitope mapping see reference 36); and (f) rabbit antibodies Cy  4 against synaptoporin (cf. 37). Specifically bound antibodies 
were detected using HRP-coupled secondary antibodies and an enhanced chemiluminescence system. 
onto the entire pantophysin molecule did not affect the lo- 
calization of the resulting chimeric molecule PS1 (Fig. 3 e), 
On  the  other  hand,  chimeras  with  transmembrane  do- 
mains from both pantophysin and synaptophysin were not 
detectable  in transfected  cells under standard  conditions, 
similar  to  the  synaptophysin-connexin  transmembrane 
chimeras described previously (41). 
To test the predicted transmembrane topology of panto- 
physin, the myc epitope was inserted into the first intrave- 
sicular  loop  domain  (construct  PM2)  that  would  be  ex- 
pected  to  be  exposed  to the  cell  surface  if the  molecule 
reached the plasma membrane during its life time. It was 
indeed possible to label transiently transfected cells by ad- 
dition of antibodies to the culture medium resulting, again, 
in  the  characteristic  multipunctate  cytoplasmic  staining 
(Fig. 3 d). 
Pantophysin Protein Detection in Neuroendocrine and 
Nonneuroendocrine Tissues 
To study pantophysin protein expression, antibodies were 
raised in chicken and rabbit against synthetic peptides cor- 
responding to the unique cytoplasmically exposed end do- 
mains.  These  antibodies  were shown to react specifically 
with the relevant pantophysin epitopes lacking cross reac- 
tivity  with  the  corresponding  domains  of synaptophysin 
Figure 5.  Double label immunofluorescence of a 5-1xm-thick, methanol/acetone-fixed cryosection of human pancreas detected by confo- 
cal laser scanning microscopy, a shows simultaneous detection of affinity-purified chicken antibodies against the carboxy-terminal pep- 
tide P-PHC3 of human pantophysin (PPH,  red fluorescence) and rabbit antibodies against the cytoplasmic carboxy terminus of synapto- 
physin (SPH,  green fluorescence). A strong immunoreactivity for pantophysin is only detectable in the exocrine portion, in blood vessel 
walls (BV), and surrounding connective tissue (S, stroma; F, fibroblast), whereas Langerhans islets are stained by both pantophysin and 
synaptophysin antibodies resulting in a yellow/orange color mixture. Partial colocalization is seen in individual  nerve fibers (N). b and c 
show the individual recordings detecting pantophysin (b) or synaptophysin (c) that were used to create the image shown in a. Bars, 50 txm. 
The Journal of Cell Biology,  Volume 134, 1996  736 Haass et al. Pantophysin:  Gene, Expression and Localization  737 Figure 6.  Double immunofluorescence microscopy of pantophysin (PPH, a) and synaptophysin (SPH, b) in cDNA-transfected synapto- 
physin-expressing PLC-derived subclone PLC-6S4. Cells were lysed with 0.25% saponin for 30 s and fixed with 2% formaldehyde for 30 
min. Pantophysin was detected with affinity-purified chicken antibodies against the carboxy terminus of human pantophysin, synapto- 
physin with mAb SY38. Note the significant colocalization of both antigens at some structures (e.g., arrows) while others are only posi- 
tive for either pantophysin (solid arrowhead) or synaptophysin (open arrowhead). Bar, 20 I~m. 
and synaptoporin  (Fig. 4) and were used for the detection 
of pantophysin  in tissues by immunofluorescence  micros- 
copy. Pancreas,  as a  tissue in which exocrine  cells can be 
compared directly with  endocrine  cells,  was examined  in 
detail.  Pantophysin  staining was strongest  in the exoerine 
portion (red in Fig. 5 a, corresponding single immunofluo- 
rescence recording in Fig. 5 b) and a weaker but still signif- 
icant  fluorescence  was  detectable  in  the  neuroendocrine 
cells  of  Langerhans  islets  that  also  expressed  synapto- 
physin  (green  in  Fig.  5  a,  single  immunofluorescence  in 
Fig. 5 c) thereby producing a yellow/orange color (Fig. 5 a). 
Nerve fibers were also positive for synaptophysin and pan- 
tophysin  although  synaptophysin  immunoreactivity  pre- 
dominated.  In  addition,  pantophysin  antibodies  reacted 
with  blood  vessel walls,  including  endothelial  and  myoid 
cells, and with connective tissue cells, while the extracellu- 
lar space of the stroma was negative. 
Pantophysin Colocalization with Cytoplasmic 
Vesicle Markers 
To further  characterize  the  pantophysin  staining  seen  in 
tissue  sections,  immunofluorescence  microscopy  of  cul- 
tured cells was performed.  Detailed  analyses of epithelial 
hepatocellular  carcinoma-derived  PLC cells, vulvar carci- 
noma-derived  A431  cells,  and  certain  subclones  thereof 
showed  that  pantophysin  was predominantly  localized  in 
dotlike  structures  in the  cytoplasm and  in a  variable pat- 
Figure 7.  Double immunofluorescence microscopy of hepatocellular carcinoma-derived PLC cells after 0.25% saponin treatment (30 s), 
2% formaldehyde fixation (30 min), and incubation with pantophysin antibodies (PPH in a-d; same antibodies as in Fig. 6 a) together with 
either affinity-purified rabbit peptide antibodies against/3-COP (a '), mAb B3/25 against the transferrin receptor (b; TFR), mAb H4A3 
against the lysosome-associated membrane protein 1 (LAMP-l) (c'), or mAb SG7C12 against secretory carrier-associated membrane 
proteins (SCAMPs) (d'). Note the partial colocalization of pantophysin and [3-COP in the Golgi region in a and a  ', the considerable 
The Journal of Cell Biology,  Volume 134, 1996  738 colocalization of pantophysin and the transferrin receptor in b and b' (arrows) besides significant differences (solid arrowheads,  struc- 
tures only labeled by pantophysin antibodies; open arrowheads, vesicles only labeled by transferrin receptor antibodies), the nonoverlap- 
ping distribution of pantophysin and LAMP-1 in c and c' with strong pantophysin staining at/or near the plasma membrane (arrows), 
and the significant colocalization of pantophysin and SCAMPs in d and d' (arrows). Bars, 20 p~m. 
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tophysin in transfected cells (see Fig. 3). 
Double  label  immunofluorescence  microscopy of the 
recently established hepatocellular carcinoma-derived cell 
line  PLC-6S4  and  the  vulvar carcinoma-derived  subline 
A431-5S4,  which  both  express  synaptophysin  in  small 
cytoplasmic vesicles (44), showed that most of the panto- 
physin and synaptophysin immunoreactivities colocalized 
although  at  different relative intensities,  and  that  a  few 
structures were only labeled by either pantophysin or syna- 
ptophysin antibodies (Fig. 6; similar results were obtained 
in A431-5S4 cells). The examination of several epithelial 
cell  lines  such  as  PLC,  A431,  and  mammary  adeno- 
carcinoma-derived MCF7  cells by double label immuno- 
fluorescence microscopy (representative results from PLC 
cells are shown in Fig. 7) revealed partial codistribution of 
pantophysin and the Golgi vesicle-associated protein 13-COP 
in  the juxtanuclear  region  (Fig.  7,  a  and  a'; cf.  15).  The 
variable perinuclear pantophysin staining (compare Fig. 3, 
b-e, Fig. 6 a and Fig. 7, a-d) may therefore, at least in part, 
be  due  to  different  orientations  of the  Golgi apparatus 
with respect to the nucleus in individual cells. Pantophysin 
also colocalized with the transferrin receptor, a marker for 
endocytotic recycling vesicles, although some "dots" were 
only positive for one or the other protein (Fig. 7, b and b '; 
cf. 44). The distribution of the lysosomal membrane pro- 
teins LAMP-1 and LAMP-2 was very different from that 
of pantophysin (Fig. 7, c and c'; cf. 41). Probably the best 
correlation was observed between the  staining of panto- 
physin and  SCAMPs,  which  are integral membrane pro- 
teins of secretory and cell surface recycling vesicles (Fig. 7, d 
and d'; see references 7, 8, 38). Furthermore, cellubrevin, a 
cellular homologue of the synaptic vesicle protein synap- 
tobrevin (47), showed significant colocalization with pan- 
tophysin in A431  cells as well (Fig. 8, a  and b) while the 
levels of cellubrevin expression in PLC cells were too low 
for immunofluorescence microscopic detection.  Given all 
these observations, pantophysin staining overlapped with 
that of markers for certain small vesicles that participate in 
shuttling, secretion, endocytosis, and recycling. 
Immunoelectron Microscopic Detection of  Pantophysin 
in Small, Electron-translucent Vesicles 
By immunoelectron microscopy, the pantophysin-contain- 
ing structures could be identified and different representa- 
tive cellular regions are shown in Fig.  9.  Abundant  gold 
particles were seen associated with small, electron-translu- 
Figure 8.  Double label immunofluorescence  microscopy of meth- 
anol/acetone-fixed  vulvar carcinoma-derived A431 cells detecting 
pantophysin (PPH)  in (a) using affinity-purified chicken antibod- 
ies against the carboxy-terminal peptide P-PPHC3 of human pan- 
tophysin  and ceUubrevin (CB) in b using affinity-purified  rabbit 
antibodies  against the cytoplasmic amino terminus of cellubrevin 
that was produced in bacteria.  Note the significant colocalization 
of individual puncta (e.g., arrows). Bar, 10 ~m. 
cent vesicles with a  diameter between 40 and 70 nm (ar- 
rows).  These  smooth-surfaced vesicles were  particularly 
abundant in regions of the cell periphery (Fig. 9 c) where 
practically all vesicles of this  size category were labeled. 
The  entire  circumference,  or only restricted  surface  do- 
mains  of these  vesicles, were  decorated  by immunogold 
(see especially high power magnifications in Fig.  9, h-j). 
Occasionally,  restricted  pantophysin  labeling  was  also 
seen at circumscribed regions (less than 50 nm extension) 
of larger vesicles (arrowheads), multilamellar and multive- 
sicular bodies (e.g., Fig. 9f'), Golgi apparatus (see, e.g., the 
Golgi-like cisterna in Fig. 9 g), peripheral ER regions (not 
shown), and plasma membrane (not shown). No immuno- 
label was associated with coated-pits and coated-vesicles 
(Fig. 9 b), mitochondria (Fig. 9 d), the nucleus (Fig. 9 d), 
or cytoplasmic filaments (Fig. 9, e and j). 
Enrichment of  Pantophysin  in Transport  Vesicles by 
Cell Fractionation 
Pantophysin-positive  vesicles  could  be  enriched  from 
A431 cells by differential centrifugation in different pellet 
Figure 9.  Immunoelectron microscopy of representative regions of vulvar carcinoma-derived  A431 cells detecting pantophysin with af- 
finity-purified chicken antibodies  against the carboxy-terminal peptide P-PHC3 of human pantophysin and 5 nm gold-coupled  second- 
ary antibodies, a-c show areas that are either next to or close to the plasma membrane and are either transverse (a and b) or tangential sec- 
tions (c). Note the presence of most gold particles around small 40-70-nm vesicles (arrows) and lack of label at cisternae  of the rough 
endoplasmic reticulum (ER), the plasma membrane (PM),  and coated pits (CP). A few larger vesicles (arrowheads) are also labeled, d 
shows cytoplasmic region next to the nucleus (N) with a single, strongly labeled small vesicle of 50 nm diameter (arrow; inset) together 
with gold particle-free membranes of the nuclear envelope (NE) and mitochondria (M). e-g depict cytoplasmic areas containing  vari- 
ously shaped vesicles and membranes. Note that in each micrograph small 40-70-nm vesicles are labeled by immunogold (arrows) but 
restricted  regions of some larger vesicles (arrowheads) and multivesicular bodies (MV;  labeled region denoted by > in./') are decorated 
by gold particles. Endoplasmic reticulum (ER) and Golgi cisternae (GA) are negative except for limited areas (e.g., region in g denoted 
by >), and no label is seen at cytoskeletal  elements including intermediate filaments (IF). h-j are high power magnifications  demon- 
strating characteristics of the small 40--70 nm electron translucent  vesicles (arrows) that are either circumferentially  labeled or only dec- 
orated by gold particles in a caplike fashion. The few larger vesicles (arrowheads) are decorated with immunolabel only at restricted  sur- 
face domains. IF, intermediate filaments. Bars, (a-h) 500 nm; (i-k) and inset in d, 50 nm. 
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in a  100,000 g  pellet (P4 in Fig. 10 a). Pantophysin immu- 
noreactivity was detected as a variable pattern of multiple 
bands in the molecular mass range of 36-45 kD, character- 
istic of an N-glycosylated protein  with  differentially  pro- 
cessed  carbohydrate  moieties  (for  different  electropho- 
retie mobility of synaptophysin see for example references 
34, 35, 39, 43, 50, 75, 76). When these pellet fractions were 
treated with Triton X-100 practically all pantophysin could 
be solubilized (prolonged exposure in Fig. 10 b). 
To characterize pantophysin vesicles in a  cell type that 
expresses synaptophysin constitutively, myc-tagged panto- 
physin PM1  (cf. Fig. 3) was expressed  in neuroendocrine 
PC12 cells. Cell clone PC12-PM3 was selected for analysis 
on the basis of its strong cytoplasmic immunofluorescence 
with myc antibodies  (not shown). Although no reproduc- 
ible  signal  was  obtained  by immunoblotting,  an  ELISA 
could  be  developed  that  allowed  the  detection  of myc- 
tagged pantophysin.  Using this assay it was shown that a 
large percentage of pantophysin immunoreactivity cosedi- 
mented with synaptophysin-containing vesicles in equilib- 
rium  or velocity gradient  centrifugation  (Fig.  11; specific 
density of peak fraction 7 in Fig. 11 a ~,,1.111 g/l). 
The composition of pantophysin vesicles was then ana- 
lyzed  by irnmunoisolation  experiments.  To  improve  the 
detectability  of the  low  amounts  of endogenous  panto- 
physin,  A431  cells  were  stably  transfected  with  a  myc- 
tagged pantophysin version (PM1; cf. Fig. 3) that also re- 
acted  with  our  pantophysin  antibodies,  together  with  a 
synaptophysin  gene  construct.  Vesicles  immunoisolated 
with pantophysin antibodies from these doubly transfected, 
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Figure 10.  Immunoblots of different cell fractions obtained from 
PLC-6S4 cells that were stably transfected with a synaptophysin 
cDNA construct. Cells were lysed in hypotonic buffer (H buffer) 
and homogenized before consecutive differential  centrifugation 
at 1,000 g, 7,000 g, 15,000 g, and 100,000 g resulting each time in a 
pellet (P1, P2, P3, and P4) and supernatant ($1, $2, $3, and $4). 
Approximately equal  amounts  of protein were loaded in each 
lane, transferred onto nitrocellulose membranes, and incubated 
with affinity-purified antibodies against the cytoplasmic carboxy 
terminus of human pantophysin. Bound antibodies were detected 
with the help of an enhanced chemiluminescence system. Arrow- 
heads on both margins show the positions of coelectrophoresed 
molecular mass markers BSA (M  r 66,000), ovalbumin (Mr 45,000), 
glyceraldehyde-3-phosphate dehydrogenase (Mr 36,000), and car- 
bonic anhydrase (M~ 29,000; not shown at fight). The weak upper 
bands in P4 are probably multimeric aggregates. Note that most 
pantophysin  immunoreactivity  is  seen  in  the  100,000-g  pellet 
(P4). (b) Pellet fractions P1-P4 were incubated overnight in H 
buffer containing 1%  Triton  X-100  and  were  recentfifuged at 
100,000 g  resulting in pellets  PI'-P4' and supernatants  S1'-$4' 
that were also subjected to immunoblotting with pantophysin an- 
tibodies as in a  (same loading scheme).  Positions of molecular 
mass markers ovalbumin (M  r 45,000) and glyceraldehyde-3-phos- 
phate dehydrogenase (Mr 36,000) are shown on the left margin. 
Note that even in the prolonged exposure practically all panto- 
physin is now detected in the soluble supernatant fractions. 
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Figure 11.  Detection  of pantophysin and  synaptophysin in su- 
crose gradient fractions of rat pheochromocytoma-defived neu- 
roendocrine  PC12  cells  stably  expressing  myc-tagged  panto- 
physin PM1 (cf. Fig. 3) by ELISA. Postnuclear supernatants were 
loaded on top of linear sucrose gradients  (15%-60%  in a  and 
15%-45% in b), each with a 70% sucrose cushion at the bottom, 
and centrifuged for either 17.5 h at 140,000 g (a) or for 160 rain at 
270,000 g (b). Fractions were collected from top to bottom (left to 
right on abscissa).  Sucrose concentration was measured with  an 
Abb6 refractometer (filled squares; scale on right ordinate in wt/ 
vol %), protein concentration was determined with the help of 
the colorimetric BioRad assay (triangles; scale on left ordinate in 
i~g/ml), and  immunoreactivities  of either mAb SY38  detecting 
synaptophysin (open squares)  or mAb MYC 1-9E10.2  reacting 
with  myc-tagged human pantophysin PM1  (circles) were  mea- 
sured by ELISA and are given as relative percentages of the max- 
imal value set as 100% (scale on left ordinate). Note the codistri- 
bution of the major immunoreactivities of both antigens. 
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vesicles that were immunoisolated from 15,000 g supernatants ob- 
tained from wild-type A431 cells (c) or A431 subclone A6S4PM18 
stably  expressing  synaptophysin  and  myc-tagged  pantophysin 
PM1 (a and b). (a) Imrnunoblots of gel electrophoretically  sepa- 
rated (SDS-PAGE) cell fractions that were immunoisolated with 
antibodies against pantophysin (PPH; affinity-purified antibodies 
against the carboxy terminus), synaptophysin (SPH; mAb SY38), 
secretory carrier-associated  membrane proteins (SCAMP; mAb 
SG7C12), and cellubrevin (CB; affinity-purified antibodies against 
the cytoplasmic amino terminus) or only with secondary antibod- 
ies (C), and were subsequently blotted with the same antibodies 
in different combinations as indicated. (b and c) Electron micro- 
graphs show that the material immunoisolated with pantophysin 
stable cells (clone A6S4PM18)  contained synaptophysin, 
SCAMPs  (Fig.  12  a,  left  column),  and  cellubrevin  (not 
shown). Fig.  12 b  shows  immunoadsorbed vesicles from 
A6S4PM18 cells that were similar to those isolated from 
wild-type A431 cells (Fig. 12 c). Conversely, pantophysin 
could be copurified in immunoisolation experiments using 
antibodies against synaptophysin, SCAMPs, and cellubre- 
vin (Fig. 12 a, upper row). 
Finally,  the  distribution  of pantophysin  and  synapto- 
physin was investigated in vivo in a human pheochromocy- 
toma as a neuroendocrine tumor known to express large 
amounts of synaptophysin (see for example reference 76). 
Strongly synaptophysin-positive tumor islets  were, how- 
ever, only weakly or not at all labeled by pantophysin anti- 
bodies (Fig.'13, a-c). Yet, immunoisolation experiments us- 
ing antibodies against either synaptophysin or pantophysin 
demonstrated unequivocally that a  certain proportion of 
synaptophysin and pantophysin molecules must be present 
in the same vesicles of the 15,000-g supernatants (Fig. 13 d) 
as is also the case for the PC12 subline PC12-PM3 that over- 
expressed myc-tagged pantophysin (Fig. 13 e; see also Fig. 
11). But it was not possible to immunodeplete the starting 
fractions completely of synaptophysin using pantophysin 
antibodies, or of pantophysin using synaptophysin antibod- 
ies even under optimized conditions indicating that some 
of the vesicles contain only either one or the other molecule. 
Discussion 
We  showed  that  the  synaptophysin  homologue  panto- 
physin is a ubiquitously expressed integral membrane pro- 
tein of a  certain type of cytoplasmic vesicle. The typical 
pantophysin vesicles have a diameter of <100 nm (average 
40-70 nm), a smooth surface and an electron-translucent 
lumen. By these criteria they are indistinguishable  from 
transport vesicles that have been described in various in- 
tracellular shuttling pathways (4, 14, 28,  48, 51-53). This 
interpretation is also supported by double label immuno- 
fluorescence  microscopy  and  immunoisolation  experi- 
ments showing that pantophysin codistributes with mem- 
brane markers for such vesicles present in the Golgi region, 
the transferrin receptor-positive recycling system connecting 
the plasma membrane and endosomes, and in ubiquitous 
secretory and endocytotic pathways that are characterized 
by the presence of the cellular vSNARE cellubrevin and the 
secretory carrier-associated membrane proteins (SCAMPs) 
(Figs. 7, 8, and 12). Interestingly, synaptophysin and pan- 
tophysin colocalize in the same small cytoplasmic vesicles 
in  transfected  nonneuroendocrine  and  neuroendocrine 
cells and  in neuroendocrine tissues  (e.g., Figs.  6,  11,  12, 
and 13; for pantophysin mRNA expression in neuroendo- 
crine and neuronal cells see also reference 40). We con- 
clude therefore that pantophysin is a marker for small cy- 
toplasmic transport vesicles independent of their cargo in 
many cell types, and thereby represents a common prop- 
erty of all these different vesicles for which it probably ful- 
fills basic structural and housekeeping functions. 
antibodies consists mostly of small diameter vesicles (40-70 nm; 
arrows) and several larger vesicles (arrowheads in b). Bars: (b) 
500 nm; (c) 100 nm. 
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rarely saw vesicles in a state of budding or docking, possi- 
bly due  to the  comparatively  short  time  period  of these 
events  during  the  life  time  of a  carrier  vesicle.  Epitope 
masking may be another plausible  reason for this lack of 
detection due to altered conformation of the antigen or to 
reduced  accessibility of the antibody.  This could also ex- 
plain why pantophysin was never detected in coated-vesi- 
cles and -pits (for synaptophysin-epitope masking in clath- 
rin-coated vesicles see reference 46). The small clusters of 
pantophysin immunogold particles which were seen in re- 
stricted regions of ER, Golgi apparatus, multivesicular bod- 
ies, and plasma membrane could therefore be the result of 
previous vesicle fusion events or indicate immanent vesi- 
cle fission  at  these  locations.  Considering  the strong and 
direct interaction of synaptophysin with v SNAREs of the 
synaptobrevin type (11, 16, 72), it will be of interest to find 
out  whether  pantophysin  interacts  with  the  widely  ex- 
pressed  synaptobrevin  isoform cellubrevin  that  we  have 
shown to be present  in pantophysin vesicles  (Figs.  8  and 
12), thereby regulating membrane fusion events. 
We have also provided compelling evidence that panto- 
physin is a member of the synaptophysin family by show- 
ing similarities in gene structure and amino acid sequence 
(see also references 40, 77). The high degree of conserva- 
tion of the transmembrane  domains and connecting intra- 
vesicular loops suggests that these regions are essential for 
basic properties common to all family members while the 
divergent cytoplasmic end domains  of synaptophysin are 
important  for certain  aspects  of regulated  exocytosis  in 
neurons. Clearly, the end domain of synaptophysin is nei- 
ther needed for intracellular  topogenesis (41) nor does it 
alter the localization of pantophysin in transfected cells as 
shown by our chimera PS1 that consists of the entire pan- 
tophysin molecule linked  to the cytoplasmic carboxy ter- 
minus of synaptophysin (Fig. 3). 
We  showed  that  the  expression  of the  synaptophysin 
Figure 13.  Colocalization of pantophysin and synaptophysin by 
immunofluorescence microscopy (a-c)  and  immunoblotting  of 
immunoisolates (d and e) of a human pheochromocytoma (a-d) 
and the rat pheochromocytoma-derived cell line PC12-PM3 (e). 
a-c shows  double  immunofluorescence microscopy and  corre- 
sponding phase contrast (c) detecting pantophysin (PPH; a) us- 
ing affinity-purified antibodies from chicken against the carboxy- 
terminal peptide P-PHC3 of human pantophysin and mAb SY38 
directed against synaptophysin (SPH; b). Note that pantophysin 
is expressed in most cells with significantly  reduced levels in the 
strongly synaptophysin-positive tumor islets. Bar, 50 p,m. (d) Im- 
munoblot of cell  fractions and vesicles  that were isolated from 
15,000 g supernatants obtained from the human pheochromocy- 
toma shown in a-c. Polypeptides were separated by 12%  SDS- 
PAGE, and synaptophysin was detected on immunoblots using 
mAb SY38  and an enhanced chemiluminescence system.  Lane 
SM contains the 15,000-g supernatant starting material (45 ixg to- 
tal protein); lane SPH contains material isolate  d with mAb SY38- 
coupled magnetic beads as positive control (the upper ,',~53-kD 
and lower N23-kD bands are due to reaction of the secondary an- 
tibodies with the heavy and light chains of SY38) next to lane C 
with material isolated with magnetic beads coated only with sec- 
ondary rat anti-mouse IgG1 antibodies as negative control; lane 
PPH vesicles  are isolated with magnetic beads coupled to affin- 
ity-purified chicken antibodies against the carboxy terminal pep- 
tide P-PHC3 of human pantophysin (,'~10 times more material 
was loaded than in lane SPH) next to lane C with material iso- 
lated  with  magnetic  beads  coated  only with  secondary rabbit 
anti-chicken IgY antibodies. Note that synaptophysin-containing 
vesicles can be immunoisolated with pantophysin antibodies. (e) 
Immunoblot of cell  fractions and  vesicles  obtained  from PC12 
subclone PC12-PM3 (e) expressing the myc-tagged pantophysin 
version PM1 (see also Figs. 3 and 11) after reaction with synapto- 
physin mAb SY38 (same procedure as in d). Lane SM shows the 
15,000-g starting material (20 Ixg total protein), lane PPH vesicles 
immunoisolated with the help of magnetic beads coupled to mAb 
MYC 1-9E10.2 against the myc epitope present in the transgenic 
pantophysin, and lane C material  isolated with magnetic beads 
coated with secondary antibodies only. Compare the results with 
those shown in d. The relative position of the coelectrophoresed 
size markers for d and e are indicated by dots at left (from top to 
bottom)  BSA (Mr  66,000),  ovalbumin (Mr  45,000),  glyceralde- 
hyde-3-phosphate dehydrogenase (Mr 36,000), and carbonic an- 
hydrase (Mr 29,000). 
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type but defines a ubiquitous vesicle of similar size and ap- 
pearance  as  the typical synaptophysin-positive  vesicle  in 
neurons and neuroendocrine cells (for example see refer- 
ences 50,  75).  Isoforms of several  other  synaptic  vesicle 
proteins  have  also been  identified that  are  expressed  in 
nonneuroendocrine cells (e.g., 7-10, 22, 24, 32, 45, 47, 58-- 
60, 63, 71). For example, isoforms of the vSNARE synap- 
tobrevin have been shown to colocalize with transferrin- 
containing  recycling vesicles in fibroblasts  (24,  47),  with 
vesicles in the ER/Golgi region of skeletal muscle (58, 71), 
with zymogen  granules  of exocrine cells and  dense  core 
vesicles of J3 cells in pancreas (9, 59), with glucose trans- 
porter--containing  vesicles  in  adipocytes  (10),  or  water 
channels in the collecting ducts of kidney (22). Conversely, 
SCAMPs  are  not only  constituents  of secretory and  en- 
docytotic vesicles in nonneuroendocrine  cells but also of 
synaptic vesicles  (7,  8, 38).  Expression  of the  individual 
family members is not mutually exclusive (see for example 
Fig.  5)  and  our  finding  that  pantophysin  and  synapto- 
physin can even colocalize in the same vesicle (Figs. 12 and 
13) is paralleled by the observed codistribution of synapto- 
physin and synaptoporin (23), of cellubrevin and synapto- 
brevins (12), or of Rab3A and Rab5 (21) in the same vesi- 
cles  suggesting  overlapping  functions  of  the  different 
family members (see also references 45, 70), a notion that 
is also supported by the lack of dramatic defects in synap- 
tophysin-deficient  mice (17)  in which pantophysin  might 
substitute for synaptophysin. 
The  presence  of  other  polypeptides  with  four  mem- 
brane-spanning domains such as the SCAMPs and synap- 
togyrins in synaptic vesicles (3, 7, 8, 64) and, at least in the 
case of the SCAMPs,  in ubiquitous pantophysin-contain- 
ing cytoplasmic vesicles of nonneuroendocrine  cells (this 
study; see also references 7, 8, 38) adds a further degree of 
complexity  and  potential  functional  redundancy.  Al- 
though there is no resemblance in primary amino acid se- 
quence  between  these  different  gene  families  there  are 
characteristic features shared by all the encoded molecules 
such  as the  same  transmembrane  topology  with  amino- 
and  carboxy-termini  facing  the  cytoplasm, and  the  ten- 
dency to form homooligomers (8, 23, 34, 64, 68) formally 
shown only for synaptophysin  and synaptoporin  (23,  34, 
68). It is possible that all these molecules perform similar 
basic functions that are important for membrane domain 
biogenesis and maintenance including regulation of vesicle 
fusion and intravesicular milieu as well (for possible func- 
tions of synaptophysin see references 11, 16, 25, 62, 68, 72). 
Different  stoichiometric  combinations  of these  polypep- 
tides could confer specific properties to a given membrane 
in a given cell. We have proposed, in the case of synapto- 
physin, that it is a major structural determinant of small 
cytoplasmic  vesicles  (39,  43,  44)  and  related  molecules 
such as pantophysin could also be important for formation 
and/or maintenance of these membranes with high curva- 
ture (see also reference 64). 
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